EPISODE · Nov 17, 2025 · 4 MIN
Pre-Session Views
from Al Ahly Pharos · host Al Ahly Pharos
In today's viewsStrategy | Nile Pharma (NIPH) is closing in on Rameda and this may trigger arbitrage opportunitiesISPH | The decline in ISPH stock price yesterday confirms that 3Q25 results are strong.VALU | 9M25 bottom line is consistent with a full year target of EGP750 million ETEL | Share price is approaching our FV upper end of EGP73/share, what is incorporated and what’s not?MFPC | 3Q soft on volumes and FX, but gas policy shield supports premium EGCH | Resilient margins supported by pricing; operational recovery yet to showEKHO | 3Q25: On track for full-year guidance; 4Q25 poised for stronger finishLCSW | Economies of scale drive strong 3Q25; weak 4Q25 to derail EGP360m earnings targetORWE | Improved 3Q25 puts ORWE on track to meet revised 2025e guidance
Embed this episode
What this episode covers
In today's views Strategy | Nile Pharma (NIPH) is closing in on Rameda and this may trigger arbitrage opportunitiesISPH | The decline in ISPH stock price yesterday confirms that 3Q25 results are strong.VALU | 9M25 bottom line is consistent with a full year target of EGP750 million ETEL | Share price is approaching our FV upper end of EGP73/share, what is incorporated and what’s not?MFPC | 3Q soft on volumes and FX, but gas policy shield supports premium EGCH | Resilient margi...
NOW PLAYING
Pre-Session Views
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.